#DisruptionDialogues Podcast focuses on the various upcoming disruptions that are changing the operating landscape of global businesses. This podcast series is designed to introduce the subject of disruption to like-minded leaders who would share insights on a host of challenges being faced by a plethora of industries, and the solutions being pitted to tackle them. In this decade alone, we expect to see each B2B company transforming 50% of their revenues. To survive these business disruptions, companies need to analyze their business processes and external environment to ascertain whether they are well equipped to rise to these challenges. According to MarketsandMarkets estimate, these disruptions are expected to create new revenue opportunities worth US$ 25 trillion by 2030.

MarketsandMarkets presents the New Economy Series - Fireside Chats to provide actionable insights on new revenue growth opportunities emerging from disruptions in the ecosystem. Episodes in this series unveil how global market and technological disruptions impact the economy. As it directly influences industries, actionable insights from industry experts can help businesses navigate through emerging challenges and act accordingly towards growth.

In this episode, we deep-dived into the future of the green chemicals industry in conjunction with sustainability and decarbonization – with the primary focus on CCUS, BIO, and Green Hydrogen. With the growing adoption of green chemicals to minimize the overall carbon footprint, there stands a lucrative market growth opportunity of US$ 232 billion by 2032.

Register Now to unlock the impending advantage in the green chemicals market!

MarketsandMarkets presents the New Economy Series - Fireside Chats to provide actionable insights on new revenue growth opportunities emerging from disruptions in the ecosystem. Episodes in this series unveil how global market and technological disruptions impact the economy. As it directly influences industries, actionable insights from industry experts can help businesses navigate through emerging challenges and act accordingly towards growth. 

In this episode, we deep-dived into the future of the CCUS and DAC technologies in conjunction with sustainability and reducing carbon footprint – with the primary focus on driving the CO2 emissions to zero. With the growing initiatives towards carbon capture, there stands a lucrative revenue opportunity of $170 million by 2025 awaits in CO2 capture alongside a billion-dollar plus market by 2030. 

Stay tuned to unlock the impending advantage in the CCUS market!

#DisruptionDialogues Podcast focuses on various upcoming disruptions that are changing the operating landscape of global businesses. This podcast series is designed to introduce the subject of disruption to like-minded leaders who would share insights on a host of challenges being faced by a plethora of industries, and the solutions being pitted to tackle them. In this decade alone, we expect to see each B2B company transforming 50% of their revenues. To survive these business disruptions, companies need to analyze their business processes and external environment to ascertain whether they are well equipped to rise to these challenges. According to MarketsandMarkets estimate, these disruptions are expected to create new revenue opportunities worth US$ 25 trillion by 2030. 

With new digital transformation trends impacting the industries, marketing community is going through a rapid change and it’s imperative to boost up the innovation process ten folds of the expected. Advancement in customer data has elevated the pressure to prove ROI. The scope of the role has increased enormously in today's leadership. A CMO’s function has evolved to promote versatile growth, and along with their responsibility to remould sales and marketing strategies, the need for a CMO to meet business acumen is utmost challenging.

Join us at the MarketsandMarkets CMO Summit London on 27th -28th June 2022. Hear from top marketers about how leading brands are adapting to the shifting landscape, behavioural trends, products, and services. Over the two days, marketing moguls will share tips and best practices on emerging technologies, automation in driving customer experience, and various opportunities and disruptions in Marketing world.

The smart manufacturing market are expected to reach USD 384 billion market in 2025. Numerous enabling technologies are expected to fuel its growth – Condition Monitoring, Artificial Intelligence, Digital Twin, Industrial 3D Printing, Collaborative Robots, Industrial Cybersecurity, Warehouse Management Systems, Manufacturing Execution System and Automated Guided Vehicle. 

This Crystal Ball event focuses on learning more about the most promising opportunities in the Smart Manufacturing ecosystem, as seen through the lens of eminent CXOs in this space.

• The global plant-based food market is expected to reach 77.8 billion U.S. dollars in 2025. The forecast projects that by 2030 the market will have more than doubled. For 2022, the model expects a market worth 44.2 billion U.S. dollars.
   
• Plant-based or plant-forward eating patterns focus on foods including not only fruits & vegetables, but also nuts, seeds, oils, whole grains, legumes, and beans.

With new digital transformation trends impacting the industries, marketing community is going through a rapid change and it’s imperative to boost up the innovation process ten folds of the expected. Advancement in customer data has elevated the pressure to prove ROI. The scope of the role has increased enormously in today's leadership. A CMO’s function has evolved to promote versatile growth, and along with their responsibility to remould sales and marketing strategies, the need for a CMO to meet business acumen is utmost challenging.

Cybersecurity is the protection of internet-connected systems such as hardware, software and data from cyberthreats. The practice is used by individuals and enterprises to protect against unauthorized access to data centers and other computerized systems.

Cybersecurity is the protection to defend internet-connected devices and services from malicious attacks by hackers, spammers, and cybercriminals

With the advent of new technological advances and surgical techniques, minimally invasive surgery has witnessed a robotic revolution in the field of surgery in the form of Da Vinci robotic systems making MIS procedures a widely accepted standard of care for most of the clinical specialties all over the world.

Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery. Advancement in pharmacogenomics and genomic technologies has allowed the clinicians to design specific treatment strategy for specific disease at the specific time.

The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness. The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Conference on 20th-21st October 2022

Pharmaceutical supply chain and logistics faced the hardest disruptions during initial COVID era. Now, with COVID therapeutic manufacturing taking space, there also is a big desire to accelerate other clinical pipeline because of the ample opportunity for new medicine. While some companies were able to cope with their contingencies plan in place, the other followed risk mitigation. It is now essential for the pharma supply chain and logistics to follow the redundancy routes.

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 4th Annual MarketsandMarkets Next Gen Bioprocessing Conference.

MarketsandMarkets is proud to announce the 5th Annual Real-World Evidence and Life Sciences Conference to be held on October 20-21, 2022 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2022.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes. Telemedicine and virtual care may also provoke a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.

Additionally with the new guidance by the FDA around data quality and data standards, the stakeholders are seeking to learn its long term impact and safety surveillance.
This conference will focus on above said significant points and hold discussions on the best practices adopted by various stakeholders with a key takeaway being better decision making.

Emerging agricultural trends involve new technologies and strategies that become more advanced over time. There have been significant changes in the agriculture sector over the past several decades and new technologies have also been introduced. All these factors have led to an expansion of the sector. Recent agricultural advances have made farming activities more comfortable and acceptable for farmers. Developments or trends such as these benefit not only the growth of agriculture, but also the lives of farmers.